Integración de la medicina personalizada frente al cáncer en el descubrimiento y desarrollo de fármacos

Carlos Garcia Echeverria, Ph.D. has served as VP, Global Head of Small Molecule Drug Discovery and Deputy Global Head of Oncology Drug Discovery and Preclinical Development at Sanofi since January 2014 and April 2010, respectively. His research activities have been mainly focused on the identification and development of inhibitors of protein and lipid kinases, proteolytic enzymes and antagonists of intracellular protein protein interactions. Dr. Garcia Echeverria received the Leonidas Zervas Award from the European Peptide Society in 2006, and has made significant contributions to the identification and development of targeted cancer therapies advancing ten drug candidates to Phase I/II clinical trials. He is an inventor on over 40 patents, and has published more than 150 peer reviewed articles, book chapters and review papers. Dry Garcia Echeverria received his Ph.D. in organic chemistry from the University of Barcelona (Spain) in 1990.

"La Fundación Ramón Areces no se hace responsable de las opiniones, comentarios o manifestaciones realizados por las personas que participan en sus actividades."

Integración de la medicina personalizada frente al cáncer en el descubrimiento y desarrollo de fármacos

Descripción

Descripción

Vídeos
Ciencias de la vida y de la materia Terapias oncológicas avanzadas

Integración de la medicina personalizada frente al cáncer en el descubrimiento y desarrollo de fármacos

Descripción

Descripción

VídeosCiencias de la vida y de la materia Terapias oncológicas avanzadas

Vídeos
Ciencias de la vida y de la materia Terapias oncológicas avanzadas